Jurgi Camblong

Person · Lausanne, Switzerland

Co-founder and CEO of SOPHiA GENETICS, the Lausanne-based clinical AI company he co-founded in 2011 as an EPFL spin-out. Camblong led SOPHiA GENETICS for over a decade from a university genomics project to a Nasdaq IPO in July 2021, raising $228M and building a federated clinical AI network used by over 780 healthcare institutions in 70 countries for genomic analysis in oncology and rare disease diagnostics.

https://www.linkedin.com/in/jurgicamblong/